Results 151 to 160 of about 45,260 (250)

MVB Maturation Responsive to KRASG12D/TP53R175H Co‐mutations Fuels Extracellular Vesicle‐hypersecretion Phenotype to Aggravate Lymphangiogenesis and Lymphatic Metastasis

open access: yesJournal of Extracellular Vesicles, Volume 15, Issue 10, October 2026.
KRAS/TP53 co‐mutation specifically induces transcriptional upregulation of FUS, which mediates EVs‐circSCARNA10 secretion to anchor lymphatic endothelial cells via promoting VEGFR3 transcription, ultimately inducing lymphangiogenesis and LN metastasis of KRASG12D and TP53R175H co‐mutated PDAC.
Jiabin Yang   +16 more
wiley   +1 more source

Mast cells and endothelial cells mediate interleukin-33 and ST2 responses in distal chronic obstructive pulmonary disease lungs. [PDF]

open access: yesAm J Respir Crit Care Med
Andersson CK   +16 more
europepmc   +1 more source

Refining the Multivariable Predictive‐Prognostic PREDICTR‐OPC Model for Survival in Surgical Escalation for Oropharyngeal Squamous Cell Carcinoma

open access: yesThe Laryngoscope, Volume 136, Issue 10, Page 4290-4300, October 2026.
The PREDICTR‐OPC model is the only prognostic classifier for oropharyngeal squamous cell carcinoma (OPSCC) that also predicts surgical outcomes. This study demonstrates that removing survivin from the model preserves its prognostic and predictive performance, with comparable discrimination, calibration, and clinical utility across training and ...
Lauren L. Zhang   +18 more
wiley   +1 more source

Clinical benefit of various HER2-directed regimens in gastrointestinal malignancies: a retrospective cohort study. [PDF]

open access: yesBMC Cancer
Khanna V   +10 more
europepmc   +1 more source

Integrative Multiomics Profiling Reveals Immune Determinants of Response to Disitamab Vedotin Plus Penpulimab in HER2‐Low Breast Cancer

open access: yesMedComm, Volume 7, Issue 10, October 2026.
This prospective single‐arm study evaluated neoadjuvant disitamab vedotin plus penpulimab in 20 patients with Stage II–III HER2‐low breast cancer. The regimen showed preliminary activity (pCR 20.0% intention‐to‐treat, 25.0% evaluable; ORR 56.3%) with manageable toxicity.
Xiaoxiao Liu   +17 more
wiley   +1 more source

CXCL14 is a novel biomarker for mast cell infiltration in the melanoma tumor microenvironment. [PDF]

open access: yesJ Dermatol Sci
Lietzau S   +8 more
europepmc   +1 more source

Colorectal Cancer: Epidemiology, Risk Factors, Signaling Pathways, Clinical Features, Screening, Diagnosis, and Management

open access: yesMedComm, Volume 7, Issue 10, October 2026.
Colorectal cancer is a heterogeneous, adaptive disease shaped by population‐level risk, genomic and epigenetic alterations, tumor ecosystem evolution, and treatment pressure. This review integrates epidemiology, risk factors, signaling networks, clinical presentation, screening, molecular diagnosis, and stage‐ and biomarker‐guided management while ...
Kairui Wan   +6 more
wiley   +1 more source

“I think people's perception that her reading is good enough. That would be a worry to me.” Mother and child perspectives of school‐related reading for children with Down syndrome

open access: yesJournal of Research in Special Educational Needs, Volume 26, Issue 4, October 2026.
Abstract There is growing interest in children's reading experiences, both volitional and those initiated by, or connected to, school‐related reading. However, the majority of this research focuses on the reading experiences of neurotypical children; limiting understanding and the potential to improve support for other groups of children.
Katie Cebula, Sarah McGeown
wiley   +1 more source

Combinatorial mechanisms specify cellular location and neurotransmitter identity during planarian neurogenesis. [PDF]

open access: yesNat Commun
Clay KB   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy